Neurocrine Biosciences is a leading neuroscience‑focused, biopharmaceutical company dedicated to discovering and developing life‑changing treatments for patients with under‑addressed neurological, neuroendocrine and neuropsychiatric disorders. The company’s portfolio includes FDA‑approved treatments for tardive dyskinesia, chorea associated with Huntington’s disease, classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids*, and a robust pipeline across core therapeutic areas. ( *in collaboration with AbbVie )
Develops overall Clinical Pharmacology scientific strategies for assigned Therapeutic Areas (TA) and contributes to the broader functional strategy. Oversees all aspects of pharmacokinetic and pharmacodynamic activities for Neurocrine’s clinical development compounds. Key member of clinical protocol development at all stages and ensures appropriate assessment of Clinical Pharmacology ...